Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia

计划入组 51 人 · 首次发布于 2014 年 3 月 20 日

Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)

计划入组 68 人 · 首次发布于 2005 年 11 月 18 日

Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS)

首次发布于 2015 年 9 月 30 日

BAY-293

Acute Myeloid Leukemia(Advesya)

MYELOID THERAPEUTICS

United States

Kineta Chronic Pain LLC

United States

JAPAN ADULT LEUKEMIA STUDY GROUP

Japan

Fedratinib Shows Efficacy in Rare Myeloid Neoplasms: Phase 2 Trial Results

Olverembatinib Shows Promise in Heavily Pretreated Chronic Myeloid Leukemia

FDA Approves Danziten, a Nilotinib Formulation for CML Without Mealtime Restrictions